Resistant Hypertension Linked to Increased Risk of Sleep Apnea

This article originally appeared here.
Share this content:
Resistant Hypertension Linked to Increased Risk of Sleep Apnea
Resistant Hypertension Linked to Increased Risk of Sleep Apnea

THURSDAY, Aug. 11, 2016 (HealthDay News) -- Among adults with hypertension, resistant hypertension (RH) is associated with increased risk of sleep apnea, according to a study published online July 18 in Respirology.

Simran K. Bhandari, M.D., from the Kaiser Permanente Los Angeles Medical Center, and colleagues conducted a retrospective cohort study involving 470,386 adults with hypertension within an integrated health system. The authors determined the rates of sleep apnea in RH and non-RH patients.

The researchers identified sleep apnea in 7.2 percent of adults with hypertension. Sleep apnea occurred in 9.6 percent of those with RH and in 6.8 percent of those with non-RH. The multivariable odds ratios were 1.16, 3.57, and 2.20 for sleep apnea in RH versus non-RH, body mass index ≥30 kg/m², and males, respectively. Sleep apnea in RH had a multivariable adjusted hazard ratio of 1.24 (95 percent confidence interval [CI], 1.13 to 1.36) for ischemic heart disease; 1.43 (95 percent CI, 1.28 to 1.61) for congestive heart failure; 0.98 (95 percent CI, 0.85 to 1.12) for stroke; and 1.04 (95 percent CI, 0.95 to 1.14) for mortality, compared to sleep apnea in non-RA individuals.

"We observed a modest increase in likelihood for sleep apnea among RH compared to non-RH patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »